Europe’s cancer medicines rules were made for a different era, says BeOne Europe chief

EU PERSPECTIVES - When it comes to cancer medicines, the EU should look beyond a purely 'Made in Europe' approach and embrace 'Made with Europe', according to Giancarlo Benelli, Head of Europe at BeOne Medicines. "Cancer does not have borders," he says, as many European patients still wait too long for innovative treatments. He argues that Europe's rules have failed to keep pace with advances in cancer care. Read more